NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/10/2026
Back to search
Official data from USPTO
CTX112
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
02/11/2026
Trademark type
Word
Nice classes
5, 42
Filing date
04/20/2022
Registration date
02/10/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/10/2026
Last transaction
02/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/24/2023
First use in commerce
03/24/2023
Drawing code
4
Owner type
99
Owner location
ZUG V8, CH
Examiner
SINGH, DEEP K
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CRISPR Therapeutics AG
Representatives
Tiffany D. Gehrke MARSHALL, GERSTEIN & BORUN LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cells for medical or clinical use in the field of CAR T cell therapy for the treatment of cancer and autoimmune diseases; pharmaceutical and biopharmaceutical agents for the treatment of cancer in the field of CAR T cell therapy; gene therapy productsgene transferregulationmodulation and delivery pharmaceuticals for the treatment of cancer in the field of CAR T cell therapy
Class 42
Gene editingmedical and scientific research for the treatment of genetic diseases and disorders in the field of CAR T cell therapy for the treatment of cancer and autoimmune diseases; gene editingpharmaceutical research and development in the field of CAR T cell therapy for the treatment of cancer and autoimmune diseases
Publications
History of USPTO decisions and trademark events.
54 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/10/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/22/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/22/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2026
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/05/2026
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
01/02/2026
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
01/02/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/09/2025
GNFR
FINAL REFUSAL E-MAILED
10/09/2025
CNFR
SU - FINAL REFUSAL - WRITTEN
10/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/10/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/12/2025
GNRT
NON-FINAL ACTION E-MAILED
06/12/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
06/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2025
ALIE
ASSIGNED TO LIE
05/15/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/30/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/03/2025
GNRT
NON-FINAL ACTION E-MAILED
02/03/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/03/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/13/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/11/2025
IUAF
USE AMENDMENT FILED
10/28/2024
EISU
TEAS STATEMENT OF USE RECEIVED
10/28/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/18/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/23/2024
PUBO
PUBLISHED FOR OPPOSITION
04/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/15/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/16/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/16/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
12/18/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
12/18/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/02/2023
GNFR
FINAL REFUSAL E-MAILED
10/02/2023
CNFR
FINAL REFUSAL WRITTEN
10/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/10/2023
DOCK
ASSIGNED TO EXAMINER
07/03/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
05/11/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
05/11/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/14/2023
GNRT
NON-FINAL ACTION E-MAILED
02/14/2023
CNRT
NON-FINAL ACTION WRITTEN
02/14/2023
DOCK
ASSIGNED TO EXAMINER
02/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/26/2022
NWAP
NEW APPLICATION ENTERED
04/23/2022
Continuous trademark protection
Get notified about every new filing that threatens CTX112 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.